Aura Biosciences Inc
NASDAQ:AURA 3:59:50 PM EDT
Earnings Announcements
Aura Biosciences Reports Q1 2022 Results
Published: 05/12/2022 20:26 GMT
Aura Biosciences Inc (AURA) - Aura Biosciences Reports First Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights.
Aura Biosciences Inc- As of March 31, 2022, Aura Had Cash and Cash Equivalents and Marketable Securities Totaling $133.3 Million.
Aura Biosciences Inc- Believes Its Current Cash and Cash Equivalents and Marketable Securities Are Sufficient to Fund Its Operations Into 2024.
Aura Biosciences Inc - Qtrly Loss per Share $0.44.
Aura Biosciences Inc- As of March 31, 2022, Aura Had Cash and Cash Equivalents and Marketable Securities Totaling $133.3 Million.
Aura Biosciences Inc- Believes Its Current Cash and Cash Equivalents and Marketable Securities Are Sufficient to Fund Its Operations Into 2024.
Aura Biosciences Inc - Qtrly Loss per Share $0.44.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.47
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.57
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.47
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.57
More details on our Analysts Page.